Lb Pharmaceuticals Inc's Comment on Sales, Marketing and Customers
The company serves customers who bill federal programs for products, including healthcare benefit programs and private third-party payors. Its markets include healthcare providers, health plans, healthcare clearinghouses, physicians—such as doctors, dentists, optometrists, podiatrists, and chiropractors—certain non-physician practitioners like physician assistants and nurse practitioners, and teaching hospitals. Additionally, the company serves manufacturers of drugs, devices, biologicals, and medical supplies eligible for payment under Medicare, Medicaid, or the Children’s Health Insurance Program. The company complies with applicable federal and state regulations related to these customers and markets.
In a strategic move poised to enhance its regulatory prowess, LB Pharmaceuticals Inc. (Nasdaq: LBRX), a forward-thinking biopharmaceutical company focused on developing treatments for neuropsychiatric diseases, has announced the appointment of Dr. James Rawls, Pharm.D., as Senior Vice President of Regulatory Affairs. This pivotal addition to the executive team reflects the company s commitment to advancing its portfolio through meticulous regulatory pathways, ultimately aiming to impact lives on a global scale.Dr. Rawls is joining LB Pharmaceuticals with an impressive track record that reinforces the company s dedication to innovation and excellence. Boasting extensive experience in regulatory affairs, parti...
Lb Pharmaceuticals Inc’s Comment on Sales, Marketing and Customers
The company serves customers who bill federal programs for products, including healthcare benefit programs and private third-party payors. Its markets include healthcare providers, health plans, healthcare clearinghouses, physicians—such as doctors, dentists, optometrists, podiatrists, and chiropractors—certain non-physician practitioners like physician assistants and nurse practitioners, and teaching hospitals. Additionally, the company serves manufacturers of drugs, devices, biologicals, and medical supplies eligible for payment under Medicare, Medicaid, or the Children’s Health Insurance Program. The company complies with applicable federal and state regulations related to these customers and markets.
Sources:
Lb Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Lb Pharmaceuticals Inc’s corporate clients.
For your research, we’ve provided 9 tables on Lb Pharmaceuticals Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
